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Sex pilus specific bacteriophage to 
drive bacterial population towards 
antibiotic sensitivity
Joan Colom1, Diego Batista2, Abiyad Baig1, Ying Tang1, Siyang Liu1, Fangzhong Yuan1, 
Aouatif Belkhiri1, Lucas Marcelino2, Fernanda Barbosa2, Marcela Rubio2, Robert Atterbury1, 
Angelo Berchieri2 & Paul Barrow1
Antimicrobial resistance (AMR) is now a major global problem largely resulting from the overuse 
of antibiotics in humans and livestock. In some AMR bacteria, resistance is encoded by conjugative 
plasmids expressing sex-pili that can readily spread resistance through bacterial populations. The aim 
of this study was to use sex pilus-specific (SPS) phage to reduce the carriage of AMR plasmids. Here, 
we demonstrate that SPS phage can kill AMR Escherichia coli and select for AMR plasmid loss in vitro. 
For the first time, we also demonstrate that SPS phage can both prevent the spread of AMR Salmonella 
Enteritidis infection in chickens and shift the bacterial population towards antibiotic sensitivity.
Antimicrobial resistance (AMR) results from both regulated and unregulated use of antibiotics and other chem-
otherapeutic agents for disease treatment in both human and veterinary medicine, and as growth promoters in 
livestock rearing1,2. Transmission of resistant bacteria is exacerbated by globalisation of the animal and food 
trades, and increased travel3. However, modern medicine relies heavily on their use and they currently remain 
essential for many medical interventions including cardiac and bowel surgery, neonatal care and cancer treat-
ment. AMR is now seen as one of the most severe global threats to health4.
The economic cost of AMR is difficult to judge, but the negative effects include medication costs and reduced 
Gross Domestic Product (GDP) estimated at between 2–3.5% globally. The yearly cost to the United States (US) 
health system has been estimated at US $21-$34 billion dollars, and more than 8 million additional days in hos-
pital4. It is estimated that by 2050, the global cost could reach $65 trillion and could lead to 10 million deaths per 
year4. Individual patients have already died from untreatable bacterial infections as a result of AMR5.
Global antibiotic consumption increased by 36% from 2000 to 2010 with 76% of this in the BRICS countries, 
which includes Brazil6. There are now signs of increasing controls on antibiotic use in many countries where his-
torically there has been none7 but the frequency of resistance to key chemotherapeutic antibiotics in pathogens 
such as Salmonella enterica and Staphylococcus aureus may nevertheless reach 100% of strains in such coun-
tries8–10. Transmissible resistance to colistin, one of the last resort antibiotics, has also been reported in humans, 
pigs and meat in China11 and several other countries.
AMR in indicator organisms such as E. coli in pigs and chickens is common in many countries9,12, with trans-
mission from livestock to human, mainly via the food chain12,13. The recent O’Neill report highlighted the role of 
E. coli, both as a commensal and pathogen, as a significant driver of resistance4. Much resistance in this organism 
is plasmid-mediated and transmissible, including resistance to antimicrobials which 20 years ago were chromo-
somally located such as quinolones and colistin. In the absence of antibiotic selective pressure, plasmid-mediated 
resistance is frequently associated with reduced fitness in bacteria14.
The World Health Organization (WHO) recently published a list of pathogens prioritised in order of greatest 
threat to human health and for which new antibiotics are urgently required15. This includes carbapenem-resistant 
and ESBL-producing members of the Enterobacteriaceae, especially E. coli and Klebsiella pneumoniae15. The 
WHO has also called for a comprehensive strategy to address AMR4,16, with tighter national regulation on antimi-
crobial use. However, even with such controls the problem of resistance will remain acute for decades. Additional 
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recommended approaches to countering AMR include improvements in diagnosis, the identification of new 
drugs, and the development of alternative approaches to tackle the problem, including the use of phages16.
Under carefully controlled conditions, lytic phages have been shown to be highly effective in controlling or 
preventing a variety of infections17,18 including E. coli septicaemia in mice, chicken and colostrum-deprived 
calves19–21 and intestinal colonisation by Salmonella22 and Campylobacter23,24. Most phages attach to surface recep-
tors which are also virulence determinants such as capsules19 or lipopolysaccharide20. Some phages are known 
to attach to a range of self-transmissible plasmid-mediated sex pili, which differ in their specificity according to 
the plasmid incompatibility (Inc) group25,26. Sex pilus-specific (SPS) phages, particularly incompatibility group 
F-specific phages, have been used in bacterial genetics for the identification of bacterial cells possessing the F fac-
tor and IncF related plasmids27. Interestingly, the level of pili expression varies depending on the plasmid. Some 
of the plasmids in the F group are classified as derepressed and constitutively express F pili in all conditions28. 
However, other natural IncF plasmids are more repressed and will only express the conjugative pili at low levels 
and under certain conditions29. The application of SPS phages should not only kill bacteria harbouring such 
plasmids, but any phage-resistant mutants should have lost the plasmid. This could result in bacteria becoming 
antibiotic sensitive, if the plasmid harboured AMR genes. We have used a model system comprising the Flac plas-
mid in a laboratory E. coli strain, and the SPS RNA phage MS230 to study plasmid loss in vitro. We also transferred 
the plasmid to a Salmonella enterica ser. Enteritidis strain to study phage activity and plasmid loss in vivo in a 
chicken model of infection. Although the F plasmid is unusual as a completely de-repressed plasmid it acts as a 
good model for this approach to addressing AMR particularly since many wild-type plasmids also show varying 
degrees of de-repression31.
Results
The F-specific phage MS2 select for loss of F-like plasmids. The effect of the SPS phage MS2 and the 
LPS-specific phage EA on plasmid population dynamics was initially tested with a highly self-transmissible Flac-
plasmid model using an E. coli J62 carrying the Flac-plasmid tagged with Tn3 (AmpR). For that, MS2 was added 
to a late mid-exponential culture of this strain at a multiplicity of infection (MOI) of 10 and incubated for 24 h. 
After incubation, 64 ± 12.0% of the bacterial population had lost the plasmid in contrast to a bacterial culture 
incubated without phage where the loss was 2.5 ± 1.5% (Fig. 1) (P < 0.001). Similar results were observed with 
the LPS phage EA, reducing a 49.7 ± 12.9% the presence of plasmid (Fig. 1, P < 0.001). Because it has been shown 
that the presence of large transmissible plasmids can sometimes reduce the growth rate of bacteria in the absence 
of the environmental conditions that select for the plasmid maintenance14,32. As such, continued passage in the 
presence of MS2 was expected to increase the percentage of the plasmid-negative derivatives. The results showed 
that after 48 and 72 h plasmid loss increased to 83 ± 3.9% under the selective pressure of phage MS2 and remained 
very low when the phage was absent (7.5 ± 4.3%). Very similar results were observed when the same experi-
ment was performed with phage EA, where plasmid carriage was reduced by up to 91 ± 2.1 (Fig. 1, P < 0.001). 
Despite these similarities, only the SPS-phage MS2 was able to reduce plasmid carriage in a S. Enteritidis P125109 
Flac::Tn3 (Fig. 1, P < 0.001). This is a consequence of the type of receptor used by the phage. A LPS phage will be 
restricted to strains closely related to each other while the SPS-phage, using the pilus encoded by the plasmid will 
not have restrictions in strain specificity. This highlights the advantage of using SPS phage over classic phage using 
LPS as a receptor to attach to the bacterial host.
Characterisation of phage-resistant bacteria. Phage MS2 activity on the highly transmissible F plas-
mid derivative Flac::Tn3 resulted in an increased fitness of phage-resistant, plasmid-free derivatives above that of 
phage-resistant, plasmid-containing mutants. Two randomly-selected phage-resistant E. coli J62 Flac::Tn3 deriv-
atives (R3 and R4) were characterised further. In both mutants MS2 adsorption was almost non-existant, being 
significantly reduced an 84.6% (R3) and 92.4% (R4) after 14 min compared to the parental Flac::Tn3 (Table 1). 
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Figure 1. Phage MS2 and phage EA influence on de-repressed plasmid pFlac::Tn3 populations over time. Bars 
show mean values of three independent experiments ± standard error. Significance was calculated using the 
Two-way ANOVA with Bonferroni post-tests. ***P < 0.001.
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Neither of these mutants could transfer the plasmid and ampicillin resistance to E. coli 711RifR (Table 1). The new 
phenotype may be explained by substantial changes in sex-pilus structure or expression. Full sequencing of the 
R4 mutant revealed a mis-sense mutation in the traJ gene (Supplementary Data 1). It is known that the traJ gene is 
a positive regulator involved in the expression of the transfer genes in plasmids33. Therefore, a missense mutation 
in it would lead to a reduced or inexistent conjugation ability as reflected by the results obtained in this section.
Phage MS2 drives Salmonella Enteritidis towards plasmid loss and antibiotic sensitivity during 
infection of chickens. The effect of phage MS2 administration on plasmid loss from a S. Enteritidis from 
which the F-like virulence plasmid had been eliminated30 and into which Flac::Tn3 was transferred, was studied 
during transmission of the strain through a group of young chickens. A standard seeder-bird experimental design 
was used in which a small number of birds within a group are infected, and transmission to in-contact (spreader) 
birds is monitored at intervals34. Although this tends to show transmission over a period of weeks in birds of more 
than few days old, it was expected that transmission between a small group of newly-hatched chickens would be 
very rapid when not treated with phage, as occurred (Fig. 2).
The results showed that MS2 controlled effectively the dissemination of the S. Enteritidis Flac::Tn3 through 
the in-contact, spreader birds for two days post-infection with only 40% and 57% of the phage-treated birds 
infected on days 1 and 2 in comparison with 93% in the untreated birds at this time (P < 0.01, P < 0.05). However, 
by 4 days post-infection the infection levels were the same in both groups (Fig. 2). In addition, 8 birds from the 
control, untreated group required euthanasia due to the severity of disease; whereas none of the birds in the 
phage-treated group exhibited clinical signs of infection. The percentage of S. Enteritidis recovered from the birds, 
which also harboured the plasmid was statistically different between the phage-treated and control groups.
From day 1, the level of plasmid carriage in the phage-treated seeder birds was very low, with a proportion 
of plasmid-free colonies ranging between 83.2 ± 5.4% to 100 ± 0.0% during the experiment (P < 0.01) (Fig. 3). 
In contrast, the level of plasmid carriage in the control group was high throughout the experiment, although the 
frequency of plasmid-free bacteria increased from 2.1 ± 2.1% to 36.6 ± 8.6% between days 1 and 6 post-infection 
(Fig. 3). However, the presence of phage MS2 was associated with a significantly higher proportion of plasmid-free 
bacteria (P < 0.01). It is clear then that phage MS2 activity in the intestine accelerates this natural process.
The results corresponded directly with the bacterial and plasmid population dynamics in the spreader birds. 
The proportion of plasmid free colonies was similar in both groups during the first two days of the experiment 
(Fig. 4). The low spread rate of S. Enteritidis in the phage-treated group reduced the difference in plasmid free 
S. Enteritidis between groups at this time. However, the situation changed completely after day 4 post-infection 
when S. Enteritidis spread was similar in both groups (Fig. 2). At that point, only plasmid-free S. Enteritidis was 
detected in the treatment group, while the proportion of plasmid-free bacteria reached a maximum of 35.0 ± 4.2% 
Plasmid MS2 sensitivity
Transfer rate 
(%)
MS2 adsorption 
(%)*
Reduction in 
adsorption (%)
Flac::Tn3 (parent) YES 95.7 ± 3.5 86.8 ± 5.1 0
Flac::Tn3 R3 NO 0.0 ± 0.0 13.4 ± 10.1 84.6
Flac::Tn3 R4 NO 0.0 ± 0.0 6.6 ± 6.6 92.4
Table 1. Plasmid transfer rate of MS2 phage-resistant Flac::Tn3 E. coli strains. *Adsorption after 14 minutes in 
contact with the strains carrying plasmids. The values presented are the mean of three independent experiments 
(n = 3) ± standard error.
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Figure 2. S. Enteritidis P125109 Flac::Tn3 spread in whole chicken flock. Phage MS2 treated group (○) and 
control animals (•). Values represent mean proportion of infected birds in the flock (n = 15). Significance was 
calculated using Fisher’s exact test. *P < 0.05; **P < 0.01.
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at day 8 post-infection in the control group (Fig. 4, P < 0.01). Similar results were observed for the populations 
of S. Enteritidis found in the caecum of the animals at days 4 and 8 post-infection (Fig. 5 P < 0.05). In the treated 
group, MS2 phage counts in the caeca were 6.9 ± 0.33 and 6.8 ± 0.13 Log10 PFU/mL at days 4 and 8 post-infection.
All plasmid-free derivatives were sensitive to ampicillin, and unlike in the in vitro studies, the few 
plasmid-carrying S. Enteritidis recovered from the treatment group remained sensitive to phage MS2. Therefore, 
the selective pressure exerted by the phage MS2 shifted the Salmonella population in the seeder birds to be 
plasmid-free. This new population spread through the flock, infecting the spreader birds and, perhaps as a result 
of greater metabolic fitness, overtook any plasmid-carrying bacteria resistant to MS2 phage.
F-like plasmid characterization. The present and a previous study35,36 concentrated on plasmids which 
are relatively de-repressed and thus highly susceptible to sex pilus-specific phage. It was important to explore the 
effect of phage on wild-type plasmids which show varying degrees of repression for the expression of sex-pilus32,37.
The majority of AMR-plasmids isolated in recent years belong to Incompatibility group F38,39. The incom-
patibility group of the plasmids from a collection of wild-type AMR E. coli strains isolated from chickens29 was 
determined by PCR40. All the plasmids belonged to incompatibility group F (Table 2). Most AMR-plasmids are 
self-transmissible but at very variable rates both in vitro and in vivo although the latter is generally several orders 
of magnitude lower41,42. To have a better understanding of these plasmid dynamics, the presence of the repressor 
finO gene of the correct size was detected by PCR and correlated with the self-transmissibility rate calculated for 
all of them (Table 2).
As expected, the de-repressed plasmid Flac::Tn3 had a very high transfer rate. In this plasmid, the repressor 
FinO is inactive due to an insertion sequence IS3a in finO43. This leads to a constitutive production of conjugative 
pili which promotes F-plasmid transmission. Despite the presence of an intact finO gene being detected in all the 
remaining F-like plasmids, four of them had almost the same transfer rates as Flac::Tn3. Only the plasmids pF16 
0 2 4 6 8 10
0
20
40
60
80
100
120
Days post-infecon
Pl
as
m
id
 fr
ee
S.
)
%(siditiretnE
**
Figure 3. Plasmid-free presence of S. Enteritidis in seeder birds. Phage MS2 treated group (○) and control 
animals (•).Values represent mean proportion of plasmid free S. Enteritidis (n = 5) ± standard error. 
Significance was calculated using the Mann Whitney U test. **P < 0.01.
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Figure 4. Plasmid-free population of S. Enteritidis in Spreader birds. Phage MS2 treated group (○) and 
control animals (•).Values represent mean proportion of plasmid free S. Enteritidis ± standard error (n = 10). 
Significance was calculated using Mann Whitney U test. **P < 0.01, *P < 0.05.
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and pF21 showed a degree of reduced conjugative ability. Therefore, the presence of an apparently functional 
FinO does not preclude relatively high transfer rates indicating a more complex control of sex- pilus expression 
and conjugation than expected.
Phage MS2 host range. We tested the ability of phage MS2 to infect the wild-type E. coli chicken strains 
carrying the semi-repressed AMR-plasmids which, of necessity, was tested in broth cultures because clear plaques 
would not form on bacterial lawns as a result of the low proportion of cells expression sex-pili (Fig. 5). This situa-
tion leads to a mixed bacterial population containing phage-resistant and phage-sensitive clones. In such condi-
tions, phage MS2 plaques could not be observed on lawns of the host in top agar, because the resistant population 
would mask an developing plaques. Therefore, the only way to assess phage MS2 infectivity was to check the 
production of new virions in broth cultures of the strains. Figure 6 shows the initial and final phage concentration 
after 24 h incubation with the host strains.
Although all the plasmids were F-like, phage MS2 replication was observed only in strains carrying plas-
mids pF16 and pF21, with phage multiplication levels similar to those found in E. coli J62 Flac::Tn3 (Fig. 6). The 
reason is the presence of F sex-pilus which is a characteristic common to the IncF/MOBF12 plasmid group44. 
However, slight changes in phage MS2 receptor TraA protein, might explain the lack of infection in some of the 
strains isolated from chickens.
Phylogenetic analysis based on traA. For the phylogenetic analysis, the nucleotide sequences of traA 
from the F-plasmids from this study were compared with the nucleotide sequences of traA from published 
F-plasmids from E. coli and E. faecalis (Fig. S1). The reference F-plasmid NC_002483.1 was used as positive con-
trol for phage MS2 infection. The phylogeny showed that the plasmids pF26 and pF28 were closely related and 
clustered together in clade 1. The reference F-plasmid NC_002483.1 was in clade 2, closer to the clade 3 which 
included pF21. The pF16 was most distantly related to pF26, pF28 and pF21 and was part of the clade 4. The 
multiple sequence comparison of the nucleotide sequence of traA showed that the reference published F-plasmid 
NC_002438.1 shared highest identity (99.73%) with the pF21 and was least identical to pF26 and pF28 (95.9%)
(Fig. S2).
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Figure 5. Plasmid-free S. Enteritidis in the caecum of Spreader birds. Phage MS2 treated group (○) and 
control animals (•), values represent concentration of plasmid free S. Enteritidis. The average for each group 
(—) ± standard error is also shown (n = 5, 10). Significance was calculated using Mann Whitney U test. 
*P < 0.05.
E. coli AMR-Plasmid Genotype Transfer rate (%)
pFlac::Tn3 F-like, finO− 95.7 ± 3.5
pF16 F-like, finO+ 20.3 ± 0.7
pF18 F-like, finO+ 80.2 ± 1.1
pF21 F-like, finO+ 23.0 ± 0.9
pF26 F-like, finO+ 99.5 ± 0.5
pF27 F-like, finO+ 100 ± 0.0
pF28 F-like, finO+ 96.8 ± 0.7
Table 2. Plasmid transfer rate after conjugation with E. coli J62 Rif R. Values are presented as the mean of three 
replicates (n = 3) ± standard error.
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The F-specific phage MS2 selects for loss of repressed F-like plasmids. The effect of passage of  
E. coli pF21 in broth with the presence of MS2 phage was monitored over several days, with the result that selec-
tion for plasmid loss was also observed (Fig. 7). Although the plasmid loss increased from 0.9% to only 4.1% 
after 23 days in contact with MS2 phage, the reduction in plasmid population was ten times higher than in the 
untreated group (0.4%, P < 0.001). In a bacterial population carrying a more repressed plasmid, fewer bacterial 
cells will express sex-pili and be sensitive to MS2 phage.
The F-specific phage MS2 blocks bacterial conjugation. To see whether the presence of phage MS2 
was able to block plasmid transfer, phage was added during a conjugation in vitro. As expected, the phage was able 
to stop transmission of Flac::Tn3, reducing the transfer rate by 99.95% (Table 3). For the repressed plasmids pF16 
and pF21, the effect of the phage was even greater as conjugation was completely undetectable.
Discussion
We have shown that lytic bacteriophages, which specifically use plasmid-associated sex pili as attachment points, 
not only have the potential to kill bacteria harbouring plasmids which are relatively highly de-repressed but also 
select for plasmid loss and block plasmid transmission. With a de-repressed plasmid, phage application led to an 
over 80% plasmid loss from a S. Enteritidis strain both in vitro and in the intestines in young chickens.
The effect of sex pilus-specific phages on plasmid stability, especially AMR-plasmids has been studied previ-
ously35,36. However, to the best of our knowledge this is the first time that this effect has been demonstrated in 
vivo. Previous reports suggested that a small number of phage of different specificities might be sufficient to cover 
the major replication types of AMR-plasmid35. Nevertheless, this might be over-optimistic as there are significant 
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Figure 6. Phage MS2 replication in AMR-plasmid E. coli strains. White bars represent MS2 titre at time 0 h, 
while black bars show the titre after 24 h incubation at 37 °C with shacking. E. coli J62 Flac::Tn3 was set as a 
positive control for phage MS2 replication. All values are the mean of three independent replicates ± standard 
error (n = 3). Significance was calculated using Mann Whitney U test. *P < 0.05.
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Figure 7. Phage MS2 effect on repressed plasmid pF21 presence over time. Phage MS2 treated group (○) and 
untreated control (•). Significance was calculated using Fisher’s exact test. *P < 0.05; **P < 0.01.
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differences in sex-pilus structure even within the F-like plasmid group45. The traA relatedness of our collection of 
F-plasmids with the published F-plasmid sequences suggests that those published plasmids which grouped with 
the pF21, pF16 and NC_002438 represent a sex-pilus structure which phage MS2 will be able to infect. Therefore, 
phage MS2 would only infect conjugative F-plasmids carrying traA sequences closely related to clades 2, 3 and 444. 
This suggests that a phage cocktail will be necessary to tackle different plasmids within the F-like plasmids.
The group of Jalasvuori has shown that phage PRD1, which attaches to the sex-pilus of IncP, N and W plas-
mids46, was able to select for plasmid loss35,36. As in that study, a small proportion of phage-resistant but never-
theless antibiotic resistant (plasmid-containing), strains arose as a result of the selective pressure of MS2 phage. 
The three Flac::Tn3 derivatives analysed here were unable to conjugate and showed complete immunity to phage 
MS2 adsorption. Genomic analysis of MS2 phage-resistant mutant R4 revealed mutations in traJ region, which 
encodes the activator of the major transfer operon in the F-plasmid47. Thus, phage activity either eliminated the 
antibiotic resistance plasmid or eliminated the capacity to transmit the plasmid further. Phage MS2 induced 
extensive loss of the de-repressed Flac::Tn3 in vitro and also a significant loss of the F-like pF21 plasmid from an 
AMR E. coli isolated from chickens. This effect was enhanced by extended contact of the plasmid carrying strains 
and MS2 phage, which was also observed for a phage PRD1 reported previously36. The lower rate of wild-type 
pF21 plasmid loss may be explained by its more repressed nature. In such repressed systems, where fewer bac-
terial population express sex-pili the effective MOI may be greater than for a completely de-repressed plasmid. 
However, plasmid transfer to a recipient population is epidemic with new recipients showing a burst of sex-pilus 
production resulting from momentary de-repression following low intracellularly concentrations of FinO and 
FinP48. Therefore, the presence of a sex pilus-specific phage in the environment at the time of conjugation activity 
could prevent plasmid transmission even if these are highly repressed. This hypothesis was confirmed, as MS2 
phage completely blocked transmission of pF16 and pF21. Similar findings were obtained with the de-repressed 
RP4 plasmid35,36. This suggests that sex pilus-specific phage administration might reduce epidemic spread of 
de-repressed and repressed plasmids.
Although the results suggest that phage administration might reduce also plasmid spread, this approach cer-
tainly shows the effect of SPS phage on plasmid carriage during normal bacterial growth, both in vitro and in vivo.
We studied the effect of MS2 phage administration on the carriage and spread of a Salmonella containing the 
de-repressed Flac::Tn3 in a chicken flock. The in vivo trial showed that in the intestines of very young chickens, 
where Salmonella may colonise nearly all regions of the gut49, the administration of phage MS2 reduced the trans-
mission of the Salmonella with the plasmid between birds by direct reduction in the numbers of plasmid-carrying 
bacteria. There was notable plasmid loss in both the birds which were inoculated directly (seeder) and in those 
where the infection occurred by contact with the directly infected birds (spreaders). Interestingly, a progressive 
loss of plasmid in the untreated animals occurred, although this was much lower than in the phage-treated birds. 
This natural plasmid loss is likely to be a consequence of the high metabolic cost of a constitutive expression of 
the transfer apparatus48 in the absence of any evolutionary pressure selecting for maintenance of the plasmid. In 
contrast to the results obtained in vitro, no phage-resistant Salmonella mutants were recovered which neverthe-
less continued to carry the plasmid. It is possible that the metabolic burden of the 100 kb F-plasmid50 made very 
difficult the competition of the plasmid-containing, phage-resistant mutants against the plasmid-free Salmonella, 
which overtook and colonized the gut much faster.
These results indicate that the use of SPS phage has a three-fold advantage against AMR bacteria where the 
resistance is plasmid-mediated, namely (i) the killing effect in environments in vitro and in vivo where good 
contact can be made between phage and sex-pilus, particularly where in vivo gut contents are fairly liquid; (ii) the 
selection of plasmid-free derivatives which could outgrow the remaining phage-resistant AMR mutants; (iii) the 
reduced ability of the phage-resistant AMR mutants to self-transmit their plasmids.
This group envisages that sex pilus-specific phages might be applied under two sets of conditions, either in a 
population (animal or human) or in an individual. In the former situation the present results suggest that, in the 
absence of antibiotic administration and pressure, widespread phage use should drive bacterial evolution towards 
plasmid and AMR loss as the bacteria multiply in and spread between individuals. Thus, despite continuing con-
cerns over phage application in the environment where phage-resistance could develop this is one situation where 
it does not appear to be a major concern since the phage-resistant derivatives are desirable. In individual treat-
ment, such as a septicaemia case, bacterial numbers may be reduced by treatment with sex-pilus specific phage 
such that the host’s immunity may be able to deal with it, as suggested previously20,21. The advantage conferred 
by plasmid loss should result in the gradual replacement by antibiotic sensitive bacterial derivative cells, which if 
transmitted to other individuals should proliferate at the expense of AMR strains.
Plasmid MS2 phage
Transfer rate 
(%)*
Reduction in 
transfer rate (%)
Flac::Tn3
— 95.7 ± 3.5 0
MOI 10 0.05 ± 0.04 99.95
pF16
— 20.3 ± 0.7 0
MOI 10 0 ± 0.0 100
pF21
— 23.0 ± 0.9 0
MOI 10 0 ± 0.0 100
Table 3. Plasmid transfer rate after conjugation with E. coli 711 Rif R with and without MS2 phage. *Values are 
presented as the mean of three replicates (n = 3) ± standard error.
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Methods and Materials
Bacterial strains, culture media. E. coli J62 lac pro trp his pFlac::Tn3 (AmpR) and Salmonella Enteritidis 
P12510951 from which the virulence plasmid had been eliminated52 and the pFlac::Tn3 introduced (AmpR) were 
used as host for phage MS2. A rifampicin resistant mutant of the Salmonella strain (AmpR, Rif R) was used for the 
in vivo experiments. A collection of plasmid-containing wild-type AMR E. coli strains isolated from poultry37 
were selected for host range, phage MS2 sensitivity and plasmid loss experiments (Table S1). E. coli J62 Rif R was 
used as recipient strain for plasmid transfer rate assessment.
Luria Bertani (LB) broth and agar (1%, Sigma) was used for routine culture of the strains. Viable counts 
of E. coli J62 pFlac::Tn3 (AmpR) and AMR strains were determined by plating dilutions on MacConkey agar 
(Sigma) with or without antibiotics. The same was done for S. Enteritidis P125109 pFlac::Tn3 (AmpR, Rif R) 
counts, using Brilliant green agar (Sigma) supplemented with the appropriate antibiotic. For dilution purposes 
Phosphate-Buffered saline (PBS) buffer was used.
Plasmid incompatibility group determination. The presence of F-like plasmids was determined by 
PCR following a previously described method40 with slight modifications. A set of primers were used to recognise 
four specific regions of replicons that are representative of plasmids belonging to the Incompatibility F group 
(Table S2). The multiplex and the singleplex PCR cycling conditions consisted of an annealing temperature of 
60 °C and 52 °C for 30 sec respectively. For both reactions, the initial denaturation step was performed at 94 °C 
for 5 min, denaturation at 94 °C for 1 min and an elongation and final extension at 72 °C at 1 min and 5 min 
respectively. The presence of the repressor finO was also detected by PCR. For that, primers were designed using 
Primer3 based on the genomic sequence NC_002128.1 (Table S2). Similar cycling conditions as for the multiplex 
PCR were used except that the extension time was run for 40 seconds. Amplicons were then analysed on 1% 
agarose gel.
Bacteriophage and propagation. Liquid lysates of phage MS230 and phage EA (10 ml) were prepared by 
inoculating mid-exponential cultures of the plasmid-carrying strain E. coli J62 at a multiplicity of infection (MOI) 
of 0.1. The mixture was then incubated overnight at 37 °C with shaking at 150 rpm. After incubation, the lysate was 
centrifuged at 10,000 × g for 10 min and filtered through a 0.45 μm syringe filter (Sartorius). In all cases, phage titres 
were determined by spotting 10 µl of decimal dilutions onto LB plates using the double agar layer method53.
Double agar layer method53.
Phage adsorption. An E. coli J62 pFlac::Tn3 culture at mid-exponential phase was infected with phage MS2 
at an MOI of 0.1. The adsorption rate was determined by taking samples every 2 min for up to 14 min. At each 
time point, adsorbed phage were removed by centrifugation at 13,000 × g. After this, the supernatant was filtered 
using 0.45 μm filter (Millipore) and unbound phage were plated on LB agar overlays containing 0.1 mL of the host 
strain. The plates were then incubated overnight at 37 °C before enumeration.
MS2 host range. Ten millilitre LB broth aliquots were inoculated with 100 µl of the relevant wild-type AMR 
E. coli strain or E. coli J62 pFlac::Tn3 overnight cultures. The mixtures were then incubated 2–3 h at 37 °C with 
shaking until the mid-exponential phase was reached. At that point, MS2 phage was inoculated at a final con-
centration of 105 PFU/mL, giving a final MOI of 0.001. One millilitre samples were taken at time 0 and 24 h and 
filtered through 0.45 µm syringe filters to check phage titre53. Significant increases between initial (0 h) and final 
(24 h) phage titre indicated phage replication in the host strain.
Effect of MS2 phage during conjugation. Overnight LB broth cultures of the recipient E. coli J62 RifR 
and donor wild-type AMR E. coli strains and E. coli J62 pFlac::Tn3 were prepared. For the conjugation 5 µL of 
both donor and recipient strain were diluted in the same 5 mL LB broth aliquot with or without MS2 phage at a 
final MOI of 10. The mixture was then incubated overnight at 37 °C without shaking. After incubation, dilutions 
were plated on MacConkey agar supplemented with rifampicin (100 µg/mL) to enumerate the recipient strain. 
Similarly, for the trans-conjugant counts dilutions were plated on MacConkey agar rifampicin (75 ug/mL) and an 
appropriate antibiotic for the donor plasmid. The plasmid transfer rate was calculated as:
( )
( )
Trans conjugant
Recepient
CFU
mL
CFU
mL
−
Plasmid population kinetics with the F plasmid. An overnight LB broth culture of E. coli J62 pFlac::Tn3 
was diluted 1/100 in two 10 mL aliquots of LB broth. The fresh cultures were incubated for 2 h at 37 °C with 
shaking. After incubation, one of the aliquots was inoculated with 100 µL of a MS2 phage preparation to give a 
final MOI of 10. Both cultures were then incubated with shaking for 24 h at 37 °C. The cultures were again diluted 
1/100 in fresh LB broth and 100 μL of MS2 phage preparation was added to treatment group as before. This pro-
cess was repeated again at 48 and 72 h. Samples were taken each 24 h and plasmid loss was studied. For this, serial 
dilutions were plated on MacConkey agar and 100 colonies were replicate-plated using MacConkey agar without 
and with ampicillin (100 µg/mL). The percentage of plasmid loss was then calculated as:






× .
Ampicillin sensitive colonies
Total number of colonies
100
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Plasmid population kinetics with a F-like repressed plasmid. An overnight LB broth culture of the E. 
coli strain carrying the pF21 plasmid (SmR) was diluted 1/100 in two 10 ml volumes of LB broth. To one of those, 
a 100 µL of MS2 phage preparation was inoculated to give a final MOI of 10. Both cultures were incubated with 
shaking for 24 h at 37 °C and were then diluted 1/100 in fresh LB broth adding 100 µL MS2 preparation as before. 
This process was continued daily for 23 days. At 0, 1, 7, 10 and 23 days after incubation a diluted aliquot of each 
culture was plated on 5 MacConkey plates, aiming for a count of 200 well separated colonies on each plate. These 
plates were incubated overnight and replica-plated to MacConkey plates with or without streptomycin (100 µg/ml) 
to which the strain was resistant. After incubation colonies which had lost the antibiotic resistance were identified 
and plasmid loss rate was calculated as mentioned above.
Characterization of AMR-plasmid isolates resistant to MS2 phage. E. coli J62 pFlac::Tn3 colonies 
which were phage-resistant after MS2 phage treatment were characterized. The presence of plasmid was tested 
by PCR with F-like plasmid specific primers40. Resistance to ampicillin was also tested by plating on MacConkey 
agar supplemented with ampicillin (100 µg/mL). Phage MS2 adsorption was performed as described previously54 
and studies of plasmid transfer rate were done as described above.
Genomic and phylogenetic analysis based on traA. Raw sequence reads generated as FastQ file for 
each F-plasmid were assembled de novo using SPAdes (v3.6.2)55. The contigs with size more than 1000 bases were 
extracted and further analysed. The nucleotide sequence of traA from the reference published F-plasmid from 
E. coli K-12, NC_002438.1 was used as a query in BLAST+56 against the genome sequences of the F-plasmids. 
The nucleotide sequences of traA from the corresponding F-plasmids were extracted using the start and end 
positions from the BLAST output. The nucleotide alignments were produced by ClustalW (CLUSTAL 2.1)57. The 
maximum likelihood phylogenetic analysis was performed using the generalized time-reversible (GTR) model 
to infer nucleotide evolution with FastTree58. The phylogeny was visualised using FigTree (http://tree.bio.ed.ac.
uk/software/figtree/).
Chicken experiment. Chicken experiments were designed following the ARRIVE guidelines (https://www.
nc3rs.org.uk/arrive-guidelines) and approved by the University of Nottingham Animal Welfare and Ethical 
Review Body (Approval Non UK 0006 Phage-mediated loss of antimicrobial resistance) and by the FCAV, UNESP 
ethical review panel. All the experiments were performed in accordance with the rules set by the University of 
Nottingham Animal Welfare and Ethical Review Body and by the FCAV, UNESP ethical review panel.
Two groups of 15 newly hatched chicks were housed separately in cages (95 × 95 × 30 cm) and provided with 
chicken mash and water ad libitum. They were placed in clean rooms at ambient temperature and provided with 
heat lamps. All birds were swabbed on receipt to check for freedom from Salmonella. The swabs were incubated in 
selenite broth and plated on to plain and rifampicin supplemented (100 µg/mL) Brilliant green agar.
Two groups of 15 newly hatched chickens (Ross 308) were infected with S. Enteritidis P125109 pFlac::Tn3 
(AmpR Rif R). One group (Treatment) was treated with MS2 phage, while the other control group was untreated. 
The birds were kept for 8 days and housed in separated rooms with appropriate precautions taken to prevent cross 
infection between rooms. All the inoculations were oral and performed using blunt feeding needles.
For the inoculations 5 birds in each group were marked with red fuchsin and inoculated at day 1 with 0.2 mL 
of an overnight culture of the S. Enteritidis pFlac::Tn3 AmpR Rif R strain. Immediately after the bacterial inocula-
tion the treatment group were inoculated orally with 0.1 mL of antacid solution (10% CaCO3) followed by 0.1 mL 
of phage MS2 suspension at 1011 PFU/mL. Each bird in the control group was dosed with 0.2 mL of an antacid 
preparation only. Phage and antacid inoculation was repeated every day during the experiment. The water in the 
treatment group was also supplemented with MS2 phage at a final concentration of 109 PFU/mL.
On days 1, 2, 4, 6 and 8 post-infection all birds were cloacal-swabbed. Swabs were taken before each phage 
inoculation and placed in tubes containing 2 mL PBS. After brief mixing on a vortex mixer each swab was plated 
in a standard manner59 on a half Brilliant Green agar plate supplemented with rifampicin (100 µg/mL). The 
plates were incubated overnight at 37 °C and scored for Salmonella presence as previously reported59. At day 4 
post-infection 5 birds were sacrificed from each group and the caecal contents processed to enumerate the inocu-
lated S. Enteritidis Rif R. This was repeated at day 8 with the remaining birds from both groups. Decimal dilutions 
of caecal contents were plated on Brilliant Green agar plate supplemented with rifampicin (100 µg/mL). The num-
bers of lactose-positive, presumed plasmid-positive (Green) and lactose-negative, presumed plasmid-negative 
(Red) colonies were checked for each animal for both cloacal and caecal samples. To confirm antibiotic sensitivity 
20 colonies of both colour types were plated onto Brilliant Green agar supplemented with rifampicin and ampi-
cillin at a 100 µg/mL. Those 40 colonies were also tested for phage susceptibility by spotting 10 µL of MS2 phage 
(109 PFU/mL) onto lawns. Phage counts in caecal contents were determined on days 4 and 8 post-infection. For 
that, the initial x10 caecal dilutions were heated at 58 °C for 30 min to kill the bacteria. Further decimal dilutions 
were made and 10 µL aliquots were plated on lawns of S. Enteritidis P125109 pFlac::Tn3 (AmpR Rif R) growing on 
rifampicin LB agar (100 µg/ml).
Statistical analysis. Phage MS2 induced plasmid loss in vitro and Salmonella spread through the chicken 
flock were analysed using Fisher’s exact test (Graphpad Prism, version 7.01). To evaluate the differences in plas-
mid presence and phage production, all bacterial and phage counts data were Log10-transformed prior to statisti-
cal analysis. For data not following a normal distribution according to the Shapiro-Wilks normality test a Mann 
Whitney U test was done. (SPSS statistics 24 software, IBM). A two way ANNOVA with Bonferroni post-test was 
performed for samples following a normal distribution.
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